As of April 2024 Cel-Sci has a market cap of $77.73 Million. This makes Cel-Sci the world's 7544th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $77.73 M | -42.82% |
2023 | $0.13 B | 32.44% |
2022 | $0.10 B | -66.57% |
2021 | $0.30 B | -33.77% |
2020 | $0.46 B | 40.75% |
2019 | $0.32 B | 312.16% |
2018 | $79.91 M | 220.19% |
2017 | $24.95 M | 96.79% |
2016 | $12.68 M | -73.66% |
2015 | $48.15 M | -9.41% |
2014 | $53.15 M | 60.78% |
2013 | $33.05 M | -60.36% |
2012 | $83.4 M | 25.15% |
2011 | $66.64 M | -60.6% |
2010 | $0.16 B | -7.63% |
2009 | $0.18 B | 419.33% |
2008 | $35.25 M | -40.29% |
2007 | $59.04 M | 26.68% |
2006 | $46.61 M | 24.99% |
2005 | $37.29 M | -14% |
2004 | $43.36 M | -37.19% |
2003 | $69.03 M | 638.47% |
2002 | $9.34 M | -58.17% |
2001 | $22.34 M |
On Apr 25th, 2024 the market cap of Cel-Sci was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $352.16 B | 452,961.90% | ๐บ๐ธ USA |
Amgen AMGN | $144.81 B | 186,199.64% | ๐บ๐ธ USA |
Xencor XNCR | $1.23 B | 1,484.61% | ๐บ๐ธ USA |
Curis CRIS | $85.28 M | 9.72% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $15.64 B | 20,023.18% | ๐ฎ๐ฑ Israel |
BioCryst Pharmaceuticals
BCRX | $0.85 B | 1,003.29% | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | $0.10 B | 29.41% | ๐บ๐ธ USA |
Eterna Therapeutics ERNA | $9.68 M | -87.54% | ๐บ๐ธ USA |